Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (521-530 of 850) with videos related to

Pageof 85
Sort By:
BJU International|November 17, 2007
A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancerAlberto Briganti, Andrea Gallina, Nazareno Suardi, et al.
Urologia Internationalis|November 28, 2018
Prediction of Complications in Radical Prostatectomy Prostate Cancer Patients: Simulated Annealing versus Co-Morbidity IndexesSami-Ramzi Leyh-Bannurah, Emanuele Zaffuto, Paolo Dell'Oglio, et al.
Scientific Reports|August 4, 2025
Anticancer activity of triterpene glycosides from the sea star Solaster pacificusSergey A Dyshlovoy, Jessica Hauschild, Malte Kriegs, et al.
European Urology|March 9, 2016
Assessment of the Rate of Adherence to International Guidelines for Androgen Deprivation Therapy with External-beam Radiation Therapy: A Population-based StudyPaolo Dell'Oglio, Hiba Abou-Haidar, Sami-Ramzi Leyh-Bannurah, et al.
BJU International|December 11, 2020
Prospective validation of microseminoprotein-β added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohortPeter E Lonergan, Emily A Vertosick, Melissa Assel, et al.
Journal of Endourology|March 22, 2008
Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sumPierre I Karakiewicz, Felix K-H Chun, Andrea Gallina, et al.
The Prostate|July 27, 2021
Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patientsMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
Urology|August 12, 2008
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancerUmberto Capitanio, Sasha Ahyai, Markus Graefen, et al.
European Urology|August 21, 2014
Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective StudyNicola Fossati, Nicolò Maria Buffi, Alexander Haese, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2008
Clinical significance of p53 alterations in surgically treated prostate cancersThorsten Schlomm, Liv Iwers, Patrick Kirstein, et al.
Pageof 85

Showing results (521-530 of 850) with videos related to

Sort By:
Pageof 85
BJU International|November 17, 2007
A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancerAlberto Briganti, Andrea Gallina, Nazareno Suardi, et al.
Urologia Internationalis|November 28, 2018
Prediction of Complications in Radical Prostatectomy Prostate Cancer Patients: Simulated Annealing versus Co-Morbidity IndexesSami-Ramzi Leyh-Bannurah, Emanuele Zaffuto, Paolo Dell'Oglio, et al.
Scientific Reports|August 4, 2025
Anticancer activity of triterpene glycosides from the sea star Solaster pacificusSergey A Dyshlovoy, Jessica Hauschild, Malte Kriegs, et al.
European Urology|March 9, 2016
Assessment of the Rate of Adherence to International Guidelines for Androgen Deprivation Therapy with External-beam Radiation Therapy: A Population-based StudyPaolo Dell'Oglio, Hiba Abou-Haidar, Sami-Ramzi Leyh-Bannurah, et al.
BJU International|December 11, 2020
Prospective validation of microseminoprotein-β added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohortPeter E Lonergan, Emily A Vertosick, Melissa Assel, et al.
Journal of Endourology|March 22, 2008
Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sumPierre I Karakiewicz, Felix K-H Chun, Andrea Gallina, et al.
The Prostate|July 27, 2021
Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patientsMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
Urology|August 12, 2008
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancerUmberto Capitanio, Sasha Ahyai, Markus Graefen, et al.
European Urology|August 21, 2014
Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective StudyNicola Fossati, Nicolò Maria Buffi, Alexander Haese, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2008
Clinical significance of p53 alterations in surgically treated prostate cancersThorsten Schlomm, Liv Iwers, Patrick Kirstein, et al.
Pageof 85